![Olivier Gouédard](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Olivier Gouédard
Direttore operativo presso Cytovia Therapeutics, Inc.
Profilo
Olivier Gouédard is currently the Chief Operating Officer at Cytovia Therapeutics, Inc. He holds an MBA from New York University, a doctorate from the University of Rennes, and an undergraduate degree from Université Paris-Saclay.
Posizioni attive di Olivier Gouédard
Società | Posizione | Inizio |
---|---|---|
Cytovia Therapeutics, Inc.
![]() Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Direttore operativo | 22/06/2021 |
Formazione di Olivier Gouédard
New York University | Masters Business Admin |
Université Paris-Saclay | Undergraduate Degree |
University of Rennes | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Cytovia Therapeutics, Inc.
![]() Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Olivier Gouédard